BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17371868)

  • 1. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
    Sasaki M; Nie L; Maki CG
    J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
    Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
    J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
    Gu J; Nie L; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear import of p53 in relation to MDM2-mediated degradation and ubiquitination].
    Li HP; Zhang YP
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):86-9. PubMed ID: 15946545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Geyer RK; Yu ZK; Maki CG
    Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
    Xirodimas DP; Stephen CW; Lane DP
    Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
    Carter S; Bischof O; Dejean A; Vousden KH
    Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
    O'Keefe K; Li H; Zhang Y
    Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal ubiquitination of p53 contributes to nuclear export.
    Lohrum MA; Woods DB; Ludwig RL; Bálint E; Vousden KH
    Mol Cell Biol; 2001 Dec; 21(24):8521-32. PubMed ID: 11713287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
    Yu ZK; Geyer RK; Maki CG
    Oncogene; 2000 Nov; 19(51):5892-7. PubMed ID: 11127820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
    Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
    Davis JR; Mossalam M; Lim CS
    Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
    Xu C; Fan CD; Wang X
    Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.
    Shimizu H; Saliba D; Wallace M; Finlan L; Langridge-Smith PR; Hupp TR
    Biochem J; 2006 Jul; 397(2):355-67. PubMed ID: 16579792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
    Nakamura S; Roth JA; Mukhopadhyay T
    Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding.
    Marchenko ND; Hanel W; Li D; Becker K; Reich N; Moll UM
    Cell Death Differ; 2010 Feb; 17(2):255-67. PubMed ID: 19927155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
    Jin Y; Zeng SX; Lee H; Lu H
    J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
    Yang L; Song T; Cheng Q; Chen L; Chen J
    Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.